Join us on Monday, November 12, 2018 for webinars on Hepatitis C Virus (HCV) Therapy Guidance and Cost-Effectiveness Considerations.
- 12:00 – 1:00 pm EST
- 3:00 – 4:00 pm EST
The webinar will provide an overview of topics that will help the attendee:
- Describe the healthcare industry’s role in preventing and controlling the spread of Hepatitis C.
- Explain the cost-effectiveness considerations for Hepatitis C treatment regimens.
- Differentiate available Hepatitis C treatment regimens, including FDA-approved indications, mechanism of action, and clinical pearls.
- Review guideline-based approaches to Hepatitis C treatment.
Lisa A. Banks, PharmD, BCGP, VP Clinical Initiatives, CareKinesis